Personalized T-cell Therapy Shows Success in Eliminating Advanced Kidney Tumor in Teenager

Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers have reported an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. A novel, personalized T-cell therapy completely regressed the tumor disease, despite multiple metastases. The individual compassionate-use treatment has been published in the New England Journal of Medicine, highlighting the potential of cellular immunotherapies for children and adolescents with solid tumors.